{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:18:52Z","timestamp":1792289932025,"version":"4.4.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s13978","type":"journal-article","created":{"date-parts":[[2011,6,6]],"date-time":"2011-06-06T23:57:34Z","timestamp":1307404654000},"page":"725","source":"Crossref","is-referenced-by-count":6,"title":["Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm"],"prefix":"10.2147","author":[{"given":"Andrew","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2011,6]]},"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=10232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:07:56Z","timestamp":1477850876000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/profile-of-xeominreg-incobotulinumtoxina-for-the-treatment-of-blepharo-peer-reviewed-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/opth.s13978","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}